Clinical Trials in Italy

Active recruiting clinical trials with sites in Italy. Select a condition below to see detailed trial listings.

Total Trials: 480 // Recruiting: 480 // Updated: Daily

Italy currently has 480 clinical trials with at least one registered site in the country, of which 480 are actively recruiting participants. The most studied conditions at Italy sites are Breast Cancer, Colorectal Cancer, Heart Failure, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including IRCCS Azienda Ospedaliero-Universitaria di Bologna, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, IRCCS San Raffaele. By stage, active Italy trials break down as Phase 1 (18), Phase 2 (40), Phase 3 (19), Phase 4 (2). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Italy

Breast Cancer 19 Colorectal Cancer 9 Heart Failure 8 Prostate Cancer 7 Stroke 7 Parkinson Disease 6 Cervical Cancer 5 Pancreatic Cancer 5 Endometrial Cancer 5 Gastric Cancer 5 Ovarian Cancer 5 Acute Respiratory Failure 4 Bladder Cancer 4 Lung Cancer 4 Diffuse Large B Cell Lymphoma 3 Cardiovascular Diseases 3 Autism Spectrum Disorder 3 Gynecologic Cancer 3 Esophageal Cancer 3 Melanoma 3

All Countries → All Trials →

Other Countries in This Region

🇬🇷Greece 🇩🇪Germany 🇫🇷France 🇪🇸Spain 🇬🇧United Kingdom 🇳🇱Netherlands 🇧🇪Belgium 🇵🇱Poland 🇸🇪Sweden 🇦🇹Austria

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology